Epsomedical Holdings Limited
Registered name: EPSOMEDICAL HOLDINGS LIMITED
Epsomedical Holdings Limited made £11.3m revenue and a £219k loss in the year to 31 Oct 2025.
Epsomedical Holdings Limited’s revenue was £11.3m in the year to 31 Oct 2025, with a loss of £219k and 92 employees. The company is classified under “activities of other holding companies” and is based in Cobham.
- Status
- Active
- Location
- Cobham, London
- Age
- 2 yrs · since 2024
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Oct 2025 |
|---|---|
| Disclosure | Full P&L |
| Profit & loss | |
| Revenue (turnover) | £11.3m |
| Cost of sales | £7.5m |
| Gross profit | £3.8m |
| Operating profit | £1m |
| Profit before tax | £819k |
| Profit after tax | −£219k |
| Profit (best available) | −£219k |
| Staff costs | £3.5m |
| Employees (average) | 92 |
| Ratios | |
| Profit margin | −1.9% |
| Gross margin | 33.3% |
| Revenue per employee | £123k |
| Profit per employee | −£2.4k |
| Cash conversion | 653% |
| Balance sheet — indirect signals, not revenue | |
| Cash at bank | £711k |
| Net assets | −£169k |
| Fixed assets | £4m |
| Current assets | £3.3m |
| Debtors | £913k |
| Deferred income | £37.3k |
| Cash from operations | £6.6m |
| Source | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- −1.9%
- Profit ÷ revenue.
- Gross margin
- 33.3%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £123k
- Revenue ÷ average employees.
- Profit per employee
- −£2.4k
- Profit ÷ average employees.
- Cash conversion
- 653%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 35.3%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.3%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 8.1%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£169k
- Cash at bank
- —
- Now £711k
- Headcount
- —
- Now 92
- Deferred income
- —
- Now £37.3k
- Fixed assets
- —
- Now £4m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (1)
- Epsomedical (Acquisitions) LimitedRev. £10.7m · Profit £1m
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Oct 2025 (profit −£219k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.